Literature DB >> 9720556

Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction.

M Hohenfellner1, D Schultz-Lampel, S Dahms, K Matzel, J W Thüroff.   

Abstract

PURPOSE: Chronic sacral neuromodulation aims at functional restoration of selected forms of nonneurogenic and neurogenic bladder dysfunction. The original technique, as described by Tanagho and Schmidt, provides unilateral sacral nerve stimulation via an implanted stimulator powering an electrode inserted into a sacral foramen. Its drawback was that the implant failed unpredictably in some patients despite previous successful percutaneous test stimulation. Therefore, we modified the stimulation technique to improve the efficacy of chronic sacral neuromodulation.
MATERIALS AND METHODS: Guarded bipolar electrodes powered by an implantable neurostimulator were attached bilaterally directly to the S3 nerves through a sacral laminectomy in 9 women and 2 men (mean age 43.4 years). Of the patients 5 had urinary incontinence due to detrusor hyperactivity and 6 had urinary retention from detrusor hypocontractility. Mean followup with repeated urodynamics was 13 months (range 9 to 28).
RESULTS: Four significant complications were encountered in 4 patients. In 10 patients the urological sequelae of the neurological disorder were alleviated significantly (50% or more), including 5 who experienced complete relief of symptoms.
CONCLUSIONS: The efficacy of chronic sacral neuromodulation can be improved by bilateral attachment of electrodes directly to the sacral nerves.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720556     DOI: 10.1097/00005392-199809010-00051

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  [Sacral neuromodulation in treatment of functional disorders of the lower urinary tract. An overview of basic principles, indications, outcomes].

Authors:  A Bannowsky; C Seif; S Sugimoto; G Böhler; C van der Horst; S Bross; P Alken; K-P Jünemann; P M Braun
Journal:  Urologe A       Date:  2003-04-04       Impact factor: 0.639

2.  Sacral nerve stimulation for the management of voiding dysfunction.

Authors:  A K Das; M D White; P A Longhurst
Journal:  Rev Urol       Date:  2000

Review 3.  [Neurourology. Current developments and therapeutic strategies].

Authors:  J Kutzenberger; J Pannek; M Stöhrer
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

Review 4.  Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.

Authors:  Robert D Mayer; Fred M Howard
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 5.  How does sacral modulation work best? Placement and programming techniques to maximize efficacy.

Authors:  Bastian Amend; Mahmoud Khalil; Thomas M Kessler; Karl-Dietrich Sievert
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

6.  Combination of sacral nerve and tibial nerve stimulation for treatment of bladder overactivity in pigs.

Authors:  Xing Li; Limin Liao; Guoqing Chen; Zhaoxia Wang; Han Deng
Journal:  Int Urol Nephrol       Date:  2017-04-18       Impact factor: 2.370

Review 7.  Neurostimulation for lower urinary tract voiding problems.

Authors:  V Grüenewald; U Jonas
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

8.  Quantification of effectiveness of bilateral and unilateral neuromodulation in the rat bladder rhythmic contraction model.

Authors:  Xin Su; Angela Nickles; Dwight E Nelson
Journal:  BMC Urol       Date:  2013-07-18       Impact factor: 2.264

9.  Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.

Authors:  Daniel S Engeler; Daniel Meyer; Dominik Abt; Stefanie Müller; Hans-Peter Schmid
Journal:  BMC Urol       Date:  2015-10-23       Impact factor: 2.264

10.  Additive Inhibition of Reflex Bladder Activity Induced by Bilateral Pudendal Neuromodulation in Cats.

Authors:  Katherine Shapiro; Natalie Pace; Tara Morgan; Haotian Cai; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Front Neurosci       Date:  2020-02-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.